Real‐Time Monitoring of the Antiseizure Drug Valproic Acid Using a Novel Point‐Of‐Care Mass Spectrometry
PoC MS could enable rapid, accurate, and matrix-tolerant bedside monitoring of VPA from whole blood, supporting personalized antiseizure therapy and real-time clinical decision.
Authors
- Xinqi Fang (ORCID: https://orcid.org/0000-0003-2391-6196)
- Junhan Wu (ORCID: https://orcid.org/0000-0002-3726-5948)
- Jiexun Bu (ORCID: https://orcid.org/0009-0001-2244-7087)
- Zheng Ouyang (ORCID: https://orcid.org/0000-0002-7932-0933)
- Wei Hua (ORCID: https://orcid.org/0000-0001-6409-5078)
- Wenpeng Zhang (ORCID: https://orcid.org/0000-0002-7018-930X)
- Hong Yuan (ORCID: https://orcid.org/0000-0002-6214-6879)
- Ying Mao (ORCID: https://orcid.org/0000-0001-8055-115X)
Institutions
- Fudan University (CN)
- Huashan Hospital (CN)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/cns.70499
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Huashan Hospital
- National Key Research and Development Program of China